Nephros, Inc. — Form 8-K Summary
Filing date: October 13, 2026. This 8-K reports a corporate governance event, not a financial reporting period or financial results.
Business context and event
The board set the 2026 Annual Meeting of Stockholders for November 25, 2026, at 11:00 a.m. Eastern Time, to be held virtually by live webcast. The record date is September 30, 2026.
Financial results and comparison
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics, and no comparison with a prior period.
Material changes and stockholder deadlines
The meeting date is more than 30 days later than the anniversary of the 2025 annual meeting, held June 16, 2025. The prior proxy-statement deadlines no longer apply. The filing sets October 23, 2026, as the deadline for Rule 14a-8 proposals, Rule 14a-19 notice of competing director nominees, and notice of other proposals for purposes of discretionary proxy voting. Submissions must be delivered to the company’s principal executive offices and comply with applicable requirements.
Outlook, risks, and unusual items
No financial guidance, outlook, contingencies, or business risks are discussed. The company says adjournment or postponement of the annual meeting will not restart or extend the stated deadlines. Voting matters and webcast instructions will be provided in the definitive proxy statement.
Key facts to verify
- Review the definitive proxy statement for the voting agenda, meeting access instructions, and any additional disclosures.
- Confirm proposal or nomination eligibility and delivery requirements; the filing advises using a method that documents delivery date.
- Note that October 23, 2026, is the stated deadline for the stockholder notices described in the filing.